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Abstract
Osteochondral defects are relatively common in weight-bearing joints of 
the lower extremities and require multiple approaches of treatment. This 
work is focused on designing three-dimensional (3D) bilayered scaffolds 
fully integrating a top chitosan/hydroxypropylmethyl cellulose layer 
(CS/HPMC) mimicking cartilage and a bottom 
chitosan/hydroxypropylmethyl cellulose/nano-hydroxyapatite layer 
(CS/HPMC/nHAp) imitating bone for the treatment of osteochondral 
defects prepared by freeze drying. Additionally, an anti-inflammatory 
drug (in the bottom layer) and an antibiotic drug (in the top layer) are 
incorporated in the form of microspheres and nanofibers, respectively, 
into these scaffolds to diminish/prevent post-surgical 
inflammation/infection through sustained release of the drugs. The 








confirmed that there is no/weak interactions between the components, 
SEM images showed that both layers of the scaffolds have homogenous 
pore distribution, and scaffolds exhibited reproducible swelling and 
degradation behavior. Drug release was shown to take place over a 
period of 14 days in PBS. The scaffolds supported the growth and 
proliferation of MC3T3 pre-osteoblast cells in vitro and have potential 
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Introduction
Osteochondral defects arising in hard tissues as a result of repeated trauma 
or diseases involving articular cartilage as well as underlying calcified 
subchondral tissue eventually lead to joint destruction, which remain an 
important clinical challenge for researchers (Martin et al. 2007; 
Levingstone et al. 2014). Cartilage defects are normally irreversible due to 
their poor intrinsic healing ability and progressive deterioration if not 
properly treated (Seo et al. 2011). The treatment options of articular 
cartilage include either conservative treatment or operative treatment 
(Falah et al. 2010). Conservative treatment is concerned with the reduction 
of symptoms rather than healing, whereas operative treatment includes 
techniques, such as, (1) autologous chondrocyte implantation, (2) bone 
marrow stimulation and (3) autografting/allografting (Bohaček et al. 2015). 
However, these approaches are still not completely successful due to 
limited accessibility, donor site morbidity, associated immune response and 
disease (Nukavarapu and Dorcemus 2013; García-Gareta et al. 2015). 
Tissue engineering can be employed to address these issues, providing 
alternate ways to regenerate tissues and aid recovery using natural and 
synthetic biomaterial-based bioresorbable tissue scaffolds (Ghasemi-
Mobarakeh et al. 2008).
Generally, two types of strategies are adopted in tissue engineering i.e. 
preparation of pristine scaffolds (Gille et al. 2013) or those loaded with 
growth factors and/or stem cells to be implanted during the surgical 
procedure (Gobbi et al. 2014). Efforts to reconstruct articular defects 
originally focused on the repair of cartilage layers without consideration of 
the lower subchondral tissue with limited success (Huey et al. 2012). 
Subsequent studies of the structure of osteochondral tissues inspired the 
development of multilayered scaffolds for the treatment of osteochondral 
defects (Levingstone et al. 2014). However, to fabricate a composite 
scaffold for osteochondral defects with properties similar to that of 
articular cartilage is challenging (Doran 2015). The main hurdle associated 
with the fabrication of multilayered scaffolds is achieving a robust 
interface between the layers (Yang and Temenoff 2009). Several attempts 
have been reported regarding the design of bilayered scaffolds for 
osteochondral defects, whereas some (e.g. Trufit  and MaioRegen ) have 
been clinically translated (Kon et al. 2011). Tissue scaffolds are commonly 
designed to have interconnectivity within their porous structures and 
mechanical strengths similar to the native tissue with a controlled 
degradation rate that matches the rate of tissue regeneration. In comparison 
to this, for in vivo osteochondral scaffolds, it is desirable for the cartilage 
layer to degrade at a faster rate than the bone layer to allow rapid cell 
migration (Sridharan et al. 2016). Bilayered scaffolds composed of silk and 
silk-nano CaP for osteochondral regeneration were produced and evaluated 
for their in vitro and in vivo behavior (Yan et al. 2014; Yan et al. 2015). Lu 
et al. (2014) also synthesized bilayered OPF scaffolds for osteochondral 
defects incorporating dual growth factor loaded gelatin microparticles. Our 
group prepared robust CS/HPMC/nHAp scaffolds for trabecular (Khan et 
al. 2015) and alveolar (Iqbal et al. 2017) bone substitutes, and based on the 
outcomes we have produced bilayer scaffolds comprising CS/HPMC on the 
top layer and CS/HPMC/nHAp on the bottom layer for use as an 
osteochondral substitute.
Hydrophilic polymer-based materials swell in water (without dissolving, 
provided that chemical or physical crosslinks exist among the 
macromolecular chains) (Sannino et al. 2009). From a clinical perspective, 
common problems arising at the site of osteochondral defects are 
inflammation and deterioration of the injury due to infections (Chen et al. 
2017). To tackle the issue a common steroidal injection of TCN is 
administered along with some antibiotic drugs therefore, we incorporated 
TCN and CFX separately, and as TCN/MS and CFX/NF in the bottom and 
top layers, respectively. A layer by layer addition method (known as the 
iterative layering technique) developed by Levingstone et al. (2014) was 
adopted to fuse both layers which result in a uniform interface.
® ®
Polysaccharide based polymers like HPMC, and chitosan are commonly 
used in drug delivery applications whereas chitosan is used in tissue 
engineering as well. This study aims to design bilayered scaffolds with a 
degree of spatially controlled drug release using natural biomaterials 
through simple freeze-drying technique and assess their in vitro behavior 
under static conditions. It was hypothesized that the presence of both 
methoxy and hydroxypropyl groups in HPMC will increase the 
crosslinking between HPMC and chitosan that will subsequently prolong 
the drug release from these scaffolds (Iqbal et al. 2017). Physical and 
chemical characterization of the scaffolds was carried out with SEM and 
FT-IR respectively. Additionally, the drug release and cytocompatibility of 
both layers were evaluated by studying cell adhesion, infiltration and 
viability using mouse MC3T3 pre-osteoblast cells in vitro.
Materials and methods
Materials
Chitosan (MW: 26,200 & degree of deacetylation: 90%) was Purchased 
from Mian Scientific and refined locally at the IRCBM COMSATS 
University Islamabad, Lahore campus. nHAp (sintering grade) was 
received from Plasma Biotal Ltd, UK. Hydroxypropyl methyl cellulose 
(HPMC; molar mass: 4.2 × 10  g/mol; methoxy contents of 28–30%, 
hydroxypropyl contents of 7–12% and degree of substitution: 0.7) was 
purchased from BDH, UK. Triamcinolone Acetonide (purity = 98.23% by 
high performance liquid chromatography) and Cefixime trihydrate were 
received as gift samples from Gean pharmaceuticals (Sheikhupura road 
Lahore Pakistan) and Al Sayyed Pharma Hattar, Pakistan respectively. 
Dichloromethane (DCM; CH Cl ) and acetic acid were purchased from 
Daejung, Korea. Ethanol (CH CH OH) was purchased from Merck 
Germany. Poly(ɛ-caprolactone) MW 80,000, Phosphate buffered saline 
tablets (PBS; 0.1 M, pH 7.4), Paraformaldehyde (PFA), Propidium Iodide 
(PI) > 94.0% (HPLC grade) and 4′,6-Diamidino-2-Phenylindole 
Dihydrochloride (DAPI) ≥ 98% (HPLC grade) were purchased from 




AAT Bioquest. Minimum essential medium (α-MEM), trypsin–EDTA and 
cell culture grade PBS were procured from Gibco, Life Technologies, 
USA. 10% Foetal Bovine Serum and 1% penicillin/streptomycin were 
purchased from Caisson, USA. MC3T3 Preosteoblast cell line used was 
from American type culture collection with ATCC # CRL-2593TM. All 
chemicals were used as received.
Fabrication of drug loaded bilayered CS/HPMC/nHAp 
composite scaffolds
Bilayer scaffolds incorporating CS/HPMC/nHAp were prepared by the 
freeze drying method described in our previous protocol (Iqbal et al. 
2017). Firstly, Chitosan 33% weight ratio was dissolved in 2% acetic acid 
and the solution was stirred gently at room temperature for 4–6 h. Then, 
the nHAp powder was added and the mixture was ultrasonicated to 
disperse the nHAp completely. Afterward, HPMC was added alone and/or 
with TCN in the form of powder and microspheres (TCN loaded PCL 
microspheres prepared previously) separately with continuous stirring for 
30 min to carry out crosslinking. The second layer was made in the same 
manner without the addition of nHAp whereas TCN was replaced with 
CFX powder and nanofibers (cefixime loaded PCL nanofibers prepared 
previously). Finally, the solution was poured into polystyrene molds and 
frozen overnight at − 40 °C. Both layers were combined through a novel 
“iterative layering” technique. The frozen layers were lyophilized for 48 h 
using a freeze dryer and the CS/HPMC/nHAp bilayered composite 
scaffolds were obtained. The control composite scaffolds were fabricated 
using the same preparation method without the addition of drugs. The 
composition of all formulations is given in the Table 1.
Table 1
















B 33 25 42 – – –

















Top control C 62 38 – – – –
TCN in 
bottom B 30 25 40 5 – –
CFX in top C 60 35 – – 5 –
TCN/MS in 
bottom B 30 20 27 5 – 18
CFX/NF in 
top C 50 32 – – 5 13
These codes are used in the main text to represent their respective formulations
Characterization of drug loaded bilayered 
CS/HPMC/nHAp composite scaffolds
Data about characterizations like Fourier transform infrared spectroscopy, 
degradation behavior, porosity and swelling studies is provided separately 
in the supplementary information section.
Scanning electron microscopy
The morphology of the obtained scaffolds was examined by scanning 
electron microscopy (SEM, VEGA3, Tescan). The samples were first cut 
into rectangular pieces using a fine sterilized razor blade and fixed on 
metal stubs. After sputter coating with gold under vacuum the samples 
were placed in the chamber for microstructural analysis. The obtained 
images were further processed using ImageJ software.
Test of mechanical properties
The compressive strength of the fabricated scaffolds is measured at room 
temperature using Electrodynamic fatigue testing machine (LFV-E 1.5 kN) 
according to the guidelines set in ASTM D5024-95a. The samples are cut 
into longitudinal shapes of (5 × 3 × 3 mm dimensions) and held in place 












1 × 10 /s and crosshead speed between 0.2 and 0.35 mm/min up to 25% 
deformation. The elastic modulus and universal compressive strength is 
measured in triplicate for all samples and average value is calculated.
In vitro drug release studies
The drug release from the fabricated scaffolds is studied in PBS (pH 7.4). 
For this purpose, 5 ml of sterile PBS is taken in 10 ml tubes. The scaffolds 
are cut into discs of equal weight and immersed in the PBS solution. The 
tubes are kept at 37 ± 0.5 °C in a shaking water bath at 40 rpm and after 
stipulated time intervals a 1 ml aliquot is withdrawn. The samples are 
analyzed for the quantification of both TCN and CFX through UV–visible 
spectrophotometer at a wavelength of 236 nm and 287 nm respectively. 
Every time an equal amount of pre-warmed fresh PBS is added to the tubes 
in order to keep the volume of dissolution medium constant. The 
calibration curves of TCN and CFX are plotted with known concentrations 
in PBS-Methanol with a (1:1) volume ratio and cumulative percent drug 
release with respect to time was calculated.
Drug release kinetics
To study the release mechanism from the drug loaded scaffolds the drug 
release data was fitted into different kinetic models including zero order, 
first order, Higuchi model, Hixon–Crowell model and Korsmeyer Peppas 
model. The kinetic models and their equations are as follows
where “Q” is amount of un-dissolved drug at time t, “K” is zero order rate 
constant and “t” is the time.
where “C ” is the initial concentration of drug, “K” is first order constant 
and “t” is the time.
−3
Zero  order  rate  equation Q = Kt
First  order  rate  equation LogC = Log −Kt/2.303Co
o
Higuchi  model  equation Q = K3√t
where “Q” represents the percent of drug released in time t, “K” is 
Higuchi’s constant and “t” is the time.
where “A ” is the initial amount of the drug, “A ” is the amount of drug 
released in time t, “K ” is the Hixson-Crowell rate constant and “t” is the 
time.
where “Mt/Mα” is the fraction of drug released at time t, “K ” is the rate 
constant incorporating the properties of macromolecular polymeric system 
and drug, “n” is the release exponent used to characterize the transport 
mechanism and “t” is the time.
Cell culture
The mouse MC3T3-E1 pre-osteoblast cell lines were purchased from 
American type culture collection (ATCC # CRL-2593TM). The cells were 
cultured in primary medium containing low glucose Minimum essential 
medium (Gibco, USA) supplemented with 10% foetal bovine serum and 
1% penicillin/streptomycin (Caisson, USA). The cells were passaged using 
trypsin/EDTA and cells from P = 5 are being used in the study and 
incubated at 37 °C in a humidified incubator with 5% CO  supply. All the 
experiments are performed in triplicate.
Cell attachment assay
For cell attachment the cells were re-suspended in culture medium after 
trypsinization and seeded on to the scaffolds (pre-sterilized in UV light) at 
a concentration of 2 × 10  cells per well in a 24 well plate. The cells were 
allowed to fully attach at the surface of scaffolds and proliferate in a CO
incubator. After 3 days of incubation the cells are fixed by dipping in 4% 
PFA (Para formaldehyde) solution for 30 min. The samples were washed 
with PBS and dehydrated using a serial dilution of ethanol solution i.e. 









50%, 60%, 70%, 80%, 90% and 100% (15 min each). The samples were 
then analyzed by SEM.
Cell migration assay
For cell migration assay an established protocol was used as described 
elsewhere (Justus et al. 2014). Briefly equal number of cells were plated in 
a 6 well plate and allowed to become confluent. Under aseptic conditions a 
vertical scratch was created gently in the cell monolayer using a sterile 
micropipette tip. The culture media and cell debris were aspirated carefully 
and replaced with fresh medium through the sides of the well wall to cover 
the bottom of the plate. An initial picture of the wound was taken after the 
scratch was made and the plate was incubated in a CO  incubator for 
different time intervals. After every time interval the plates were removed 
from incubator, placed under an inverted microscope and picture was taken 
to check for gap closure. A graph was then plotted between the gap closure 
and time.
Cell viability and proliferation assay
Alamar blue assay
For quantitative determination of cell viability alamar blue assay was 
performed. For this purpose, exponentially growing cells were used. The 
live cells were estimated with trypan blue staining and counted using 
hemocytometer. The sample discs were sterilized using 70% ethanol and 
UV light before starting the assay and placed in a 24 well plate. The cells 
were seeded at a density of 2 × 10  cells per well in triplicate and 
incubated for 2  and 8 days in a humidified 5% CO  incubator at 37 °C. 
After each time point, alamar blue working solution was made and added 
to the individual wells (200 µl/2 ml). Incubated for 4–5 h in a CO
incubator and measured the absorbance at 550 and 620 nm using a 
microplate reader (Biorad PR4100 absorbance Microplate reader). Cells 
without the addition of sample were used as positive controls.





For live and dead cells viability assay, equal number of cells were seeded 
on each sample in a 24 well plate and incubated for 9 days in 5% CO
incubator. After the specified period, the cells proliferation medium was 
aspirated from the wells and were incubated in dark with 3 µM Calcein 
AM and 2.5-5 µM propidium iodide in DPBS (400 µl for 24 well plate) for 
30 min. Images were recorded immediately using fluorescent microscope 
under green and red filters. The samples were then washed with PBS and 
again stained with DAPI solution which enables the nucleus to retain the 
blue dye. The scaffolds were observed under fluorescent microscope where 
live cells showed blue fluorescence upon exposure to the fluorescence 
light. The images were further analyzed using ImageJ software.
Statistical analysis
The data is presented as a mean ± standard deviation. The criteria for 
statistical significance is set with a probability value of p < 0.05.
Results and discussion
Scanning electron microscopy
SEM images (e.g. in Fig. 1a, b) show a clear interface between the top and 
bottom layers. This interface clearly distinguishes between the two layers 
which are supposed to release two different drugs and support the growth 
of bone and cartilage forming cells due to their bioactive nature. The 
porosity at 100× magnification shows that cartilage control (C ) is more 
porous than bone control (B ) as shown in Fig. 1c, d which was further 
confirmed by measuring the porosity (see in the supplementary data sheet). 
This difference in porosity is caused by the presence of nHAp crystals in 
B . The pore size in B  is also smaller than C  which is attributed to the 
existence of a strong interactions between chitosan and nHAp. The pore 
size also effects the mechanical properties, i.e. the denser the scaffold the 
more strength it exhibits as compared to porous ones, however, small pore 
sizes and denser walls limit cell migration and perfusion inside 3D 
scaffolds (Whited et al. 2011). A uniform distribution of nHAp crystals 






in the C  (F). This indicates that no leaching of the nHAp from bottom to 
top layer happened during the freeze drying. The EDX analysis also 
confirmed it where the peaks of both calcium and phosphate appears in B
while absent in C  as shown in Fig. 2. The presence of microspheres in B
layer is also visible inside the pores pointed with yellow arrow heads 
Fig. 1g and were added for providing prolonged release of the drug 
however their presence also affected the strength and degradation of the 
scaffolds. The distribution of microspheres inside the pores was good in 
case of in situ loading rather than the post seeding method. The smaller 
size of microspheres (2–100 µm) than the pore size seems to be 
responsible for the even distribution without affecting morphology. The 
nanofibers are also embedded and distributed uniformly throughout the 
pore walls of C  layer as can be seen in the cross-sectional examination at 
a higher resolution i.e. 500× Fig. 1h. These results indicate that blending 
CS/HPMC/nHAp in different weight ratios to fabricate porous 3D bilayer 
composite scaffolds is accomplishable/realistic and in situ loading of 
microspheres and nanofibers didn’t affected the surface morphology of the 
scaffolds.
Fig. 1
SEM images of the bilayered scaffolds showing two distinct layers separated 
by dotted lines (a, b), detailed SEM analysis of B  and C  layers taken at 
×100 magnification as shown in c and d. The presence of nHAp crystals on 
the surface of pore walls at ×500 magnification in B  layer while absence in 
C  layer as shown in e and f. Clearly visible microspheres inside the pores of 
B  layer and nanofibers embedded in pore walls of C  layer can also be seen 










EDX analysis of B  and C  showing the peaks of Ca  and PO  in the 





Test of mechanical properties
The mechanical strength is a very important parameter in hard tissue 
engineering especially in weight bearing areas. Studies have shown that 
decreasing wall thickness will result in enhanced interconnectivity 
(Robinson et al. 2014). Studies also suggest that reducing porosity and 
increasing wall thickness can increase compressive modulus but at the 
same time reduces cell infiltration (Bouville et al. 2014; Ruiz-Cantu et al. 
2016). An ideal scaffold for bone regeneration should have optimal 
porosity and needs to be strong enough to bear the load during the healing 
period (Polo-Corrales et al. 2014). The results of compressive strength of 
the fabricated scaffolds with different compositions are shown in Fig. 3. It 
is evident from the results that B  and B  didn’t shown much difference in o 1
the elastic modulus i.e. 3.1674 ± 0.8244 MPa and 3.1105 ± 0.8295 MPa, 
however, there is a marked difference in their compressive strengths i.e. 
0.2078 ± 0.0224 MPa and 0.2665 ± 0.0235 MPa, respectively. The same 
kind of relationship was previously observed by Uswatta et al. (2016) and 
Beşkardeş et al. (2015). When these results are compared with B , an 
increase in the elastic modulus was seen (3.6950 ± 1.7460 MPa) while the 
compressive strength remained similar to B  (0.2614 ± 0.0522 MPa). This 
increase in elastic modulus is attributed to the presence of PCL 
microspheres within the pores which exhibited some plasticizing 
properties. On the other hand, the formulation C  and C  also exhibited a 
similar behavior to B  and B  in case of elastic modulus, i.e. 0.7643 ± 
0.6436 MPa and 0.7558 ± 0.1764 MPa, while a contrast to the previous 
result is seen in case of mechanical strength, i.e. 0.0754 ± 0.0412 MPa and 
0.0865 ± 0.0051 MPa, respectively. This is because of the absence of nHAp 
in top layer and also because of the similar micromeritic properties of 
chitosan and CFX. The formulation C  displayed increased elastic modulus 
(0.9527 ± 0.3148 MPa) and also compressive strength (0.1159 ± 
0.0319 MPa) which is because of the plastic nature of PCL nanofibers 
embedded in the pore walls of the top layer of scaffold. The mechanical 
strength of these scaffolds is because of the existence of a strong chemical 
crosslinking between chitosan and HPMC whereas in contrast the physical 
interaction results in reduced strength and stiffness which was previously 
reported by (Ghasemi-Mobarakeh et al. 2015). It was also reported that 
increasing the degree of crosslinking results in promotion of bone 
regeneration through stem cells.
Fig. 3







In vitro drug release studies
The drug release data is obtained for both drugs separately. For this 
purpose, the standard curves are initially plotted for both drugs and percent 
drug release data is calculated. From the release data shown in Fig. 4 (see 
also Table S1 in supplementary data sheet), it can be assessed that both 
drugs are released in a sustained manner from their respective 
formulations. B  and C  were able to prolong the release up to 14 days 
than B  and C  which released their maximum drug load at day 7. By 




time points and within 24 h almost 40% of drug is released. By comparing 
this data with C  a little bit slow release pattern is noted and at the end of 
24 h only 23% of drug is released which is due to the presence of high 
HPMC contents in the top layer than the bottom layer. In both these 
formulations a sudden increase in drug release is also noted between 48 
and 72 h which seems to be due to some loosely bound drug that was lost 
by surface erosion started. The B  released 95.37% and C  released 
85.90% of drug in 7 days. Whereas B  released the drug in a sustained 
manner for 14 days which meets the objectives of the study. In a similar 
way to C , the C  exhibited a sustained release pattern which is again 
because of the presence of higher HPMC contents in the top layer, (HPMC 
is commonly used in sustained release formulations to prolong drug 
release). The maximum amount of drug release noted from B  and C  after 
day 14 is 87.91% and 83.13% respectively. These results show that the 
developed scaffolds have the potential to release the drugs for prolong 
period of time and should reduce the concurrent administration of the 
incorporated drugs during in vivo evaluation.
Fig. 4
Drug release profile of all four formulations containing simple blended drugs 








The release data after fitting into various kinetic models is presented in 
Table 2. According to the data there is a linear relationship among the drug 
release and time, however, the best fit is found in Higuchi’s rate equation 
with an R  value of 0.983 which best elucidates the drug release from 
micro/nano drug delivery systems. As the regression value obtained from 
all formulations is higher than 0.45 (diffusion co-efficient) therefore 
following non-Fickian diffusion mechanism. This also shows that the drug 
release from matrices is not dependent on the concentration of drug. The 
2
 
data in tabulated form is presented in Table 2 (see also Figures S5–S9 in 
supplementary data sheet).
Table 2
Data showing in vitro release kinetics (analyzed by regression co-efficient method) from all formulations
Formulation





R K R K R K R K R
B 0.729 0.285 0.367 0.008 0.928 6.052 0.941 -0.012 0.893
B 0.797 0.251 0.417 0.008 0.963 5.204 0.920 -0.006 0.938
C 0.838 0.299 0.479 0.009 0.968 6.053 0.983 -0.010 0.961
C 0.893 0.249 0.534 0.010 0.983 4.928 0.967 -0.006 0.986
AM anomalous (non Fickian) diffusion
Cell culture
Cell-substrate interactions are a crucial step for various cellular functions 
including motility, proliferation, differentiation and apoptosis. The 
biocompatible nature of a material is revealed by the initial adhesive 
response of the cell towards the biomaterial surface. Cell attachment, 
viability and proliferation of Mouse MC3T3-E1 pre-osteoblast cells on 
both layers of the scaffold was studied.
Cell attachment assay
To understand the biocompatible nature of the scaffolds, we analyzed these 
scaffolds for in vitro cell attachment studies using scanning electron 
microscopy after 3 days of incubation. For every cell, the first step is to 
adhere at the material surface and after attachment the protrusion of 
filopodia from the surface to communicate with the surrounding 
environment. From the SEM images shown in Fig. 5, it is evident that 
these scaffolds have biocompatible surface which supported the attachment 
and growth of MC3T3-E1 cells in both bottom and top layers. Cell 





adherence and cytoplasmic extensions can be seen in all samples as 
pointed by yellow arrows, and uniform layers of cells are evident even 
after 3 days of incubation. This also shows that cells are not only adhered 
to the surface of the scaffolds but have also proliferated inside the pores 
which are particularly evident in case of C  and C . The formation of cells 
layers shows that the MC3T3-E1 cells have high affinity towards these 
scaffolds. These results are consistent with the results of other researchers 
(Akman et al. 2010; Niu et al. 2011). On the other hand, the presence of 
both drugs in B  and C  as well as in B  and C  didn’t affected the 
cytocompatibility safety profile of the designed scaffolds. The appearance 
of microarchitecture inside the pore walls after degradation as shown by 
the blue arrows is also an additional benefit which provides greater surface 
area for the attachment and transport of cells inside the pore walls and 
allows the scaffold to be completely replaced with body tissue over time.
Fig. 5
Cell attachment of Mouse MC3T3-E1 pre-osteoblast cells on the scaffolds: 
bone control i.e. B  (a), cartilage control i.e. C  (b), TCN in bottom i.e. B
(c), CFX in top i.e. C  (d), TCN/MS in bottom i.e. B  (e), CFX/NFs in top 
i.e. C  (f)
o 1





The results of the wound healing method are presented in Fig. 6. Images 
were recorded in the presence of materials along with a positive control. 
From the images it is evident that the cells were migrating from both edges 
to fill the gap with respect to time. Initially a 1 mm incision was made in 
the cells monolayer using a sterilized micropipette tip. The time zero 
image is shown in Fig. 6a. After incubation the cells started migration from 
both ends and covered almost 40% of the area in 4 h which reached up to 
50% in 6 h. In the graph it is seen that initially the migration was a bit slow 
up to 6 h and then becomes linear which is probably because of the cells 
adaptation to the new environment at the start of the assay. The cells 
covered about 75% of the gap by the end of 12 h. The gap becomes totally 
confluent after about 15 h which is again a very good sign of the 
biocompatibility of the developed scaffolds. From these results it can be 
estimated that 15 h is the optimum time for MC3T3 Pre-osteoblast cells to 
migrate from one edge to the other and fill a gap of 1 mm. When the 
regression co-efficient was applied it gave a linear relationship with R
value of 0.971 which further endorsed the results. Figure 6 represents the 
results of B .
Fig. 6
Cell migration assay: at time 0 (a), after 6 h (b), after 12 h (c). Graph 
showing the relationship between gap width and time (n = 3)




Alamar blue cell proliferation assay in kinetic mode was used to check the 
cell viability. The results shown in Fig. 7 compares the cell’s growth with 
respect to time for all formulations. Cells growth at day 2 was slower than 
control because it took some time for the cells to adopt themselves to the 
new environment, however, once the cells entered the exponential phase a 
marked increase in cells growth was observed (day 8) which is an indicator 
of the biocompatible nature of these scaffolds. This increase in 
fluorescence at day 8 confirmed that cells are metabolically active and 
started proliferation inside the pores of scaffolds. Similar results were 
previously reported by other researchers (Zhang et al. 2012; Koç et al. 
2016). This also shows that the presence of both drugs has no effect 
towards cell viability as the drug release was continuous and its 
concentration increased with time. The same was reflected in cell 
attachment studies where the cell adherence to the surface and cytoplasmic 
extensions across the pore walls confirmed that these scaffolds are 
biocompatible.
Fig. 7
Alamar blue assay representing cell proliferation after 2 and 8 days of 
incubation (n = 3)
Live/dead assay and Nuclei staining
The live/dead staining was performed to determine cell viability after 
3 days of incubation. The cells were visualized by fluorescence microscope 
where viable cells stained green and dead cells as red. Figure 8a shows that 
all samples contained sufficient number of viable cells. The images show 
cells spreading not only on the surface but the ingrowth inside the pores. 
These results show that the scaffolds have good cytocompatibility. This 
data also reinforces the results of alamar blue assay where the number of 
metabolically active cells exceeded than the control at the end of 8 days 
incubation. These results strongly suggest that the scaffolds have 
biocompatible surfaces and adequate porosity which facilitates cell 
attachment and proliferation. Nuclei staining (blue color) using DAPI was 
carried out further to confirm the attachment and alignment of MC3T3-E1 
cell lines. DAPI staining showed that all the scaffolds were covered with 
cells and they proliferated inside the pores which depicts that with time 
these cells will find space to grow and replace the scaffold with native 
ECM Fig. 8b.
Fig. 8
a Live/dead assay of the prepared scaffolds, bone control; B  (A), cartilage 
control; C  (B), TCN in bottom; B  (C), CFX in top; C  (D), TCN/MS in 
bottom; B  (E), CFX/NFs in top; C  (F) and b samples after DAPI staining, 
bone control; B  (A), cartilage control; C  (B), TCN in bottom; B  (C), CFX 







This work demonstrates the feasibility to prepare CS/HPMC/nHAp bilayer 
scaffolds by means of freeze-drying technique. The novel 3D- bilayer 
scaffolds as (CS/HPMC) mimicking cartilage top layer and a bottom layer 
(CS/HPMC/nHAp) imitating bone, exhibit physicochemical properties that 
appear to make them a suitable candidate to be used as a supportive 
structure for cells functions. The combination of HPMC and chitosan in 
both layers resulted in sustained release profile for both drugs over a 
period of 7 days which positively supported our hypothesis. This was due 
to the presence of methoxy and hydroxypropyl groups in the structure of 
HPMC that strongly binds with chitosan (Khan et al. 2015). The addition 
of drugs in the form of microspheres and nanofibers was successful and 
they provided a prolonged drug release up to 14 days. The results of 
mechanical properties show that the scaffolds have good mechanical 
properties which remain the prime objective behind the designing of 
scaffold for load bearing areas. Moreover, the in vitro cell culture studies 
demonstrated that both HA and CS layers provide an adequate 3D support 
for the attachment, proliferation and differentiation of MC3T3-E1 into 
osteoblasts and chondrocytes, respectively. The CS/HPMC/nHAp based 
bilayer scaffolds are advantageous by several reasons, namely, they can be 
designed with several sizes and controlled architecture to fit patient 
specific injuries and cell functions, respectively. The CS/HPMC/nHAp 
bilayered scaffolds showed promising biological behavior and may 
therefore find applications in tissue engineering of bone and osteochondral 
defects however in vivo evaluation of these scaffolds is our next objective.
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